Speciality Medicines Peer Comparison

BSE: 544738

₹148.00

₹-2.10 (-1.40%)

As on 01-Sep-2026 13:14IST

Market cap

₹132 Cr

Revenue (TTM)

₹58 Cr

P/E Ratio

10.1

P/B Ratio

1.9

Div. Yield

0 %

Edit

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Market cap (₹ Cr)	132	7,859	183	137	38
Revenue (₹ Cr)	58	7,128	38	107	31
Net Profit (₹ Cr)	8.61	167.66	9.79	4.80	4.12
Net Margin (%)	14.70	2.35	25.56	4.46	13.20
RoE (%)	37.85	7.58	99.59	14.91	39.41
Price to Earnings	10.11	62.67	15.28	27.37	9.33
Price-To-Book	1.85	4.53	--	--	1.60

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Operating Revenue	58.27	5,095.78	38.20	106.81	28.06
Total Income	58.54	5,135.29	38.33	107.59	28.06
Total Expenditure	49.14	4,924.23	22.82	98.22	22.00
EBITDA	9.13	171.55	15.37	8.59	6.06
Depreciation	0.20	30.69	1.01	0.69	0.25
EBIT	8.93	140.86	14.37	7.90	5.81
Interest	0.51	41.62	1.35	2.15	1.95
Other Income	0.27	39.51	0.13	0.78	--
Exceptional Items	--	--	--	--	--
Profit before Tax	8.69	138.74	13.14	6.52	3.86
Provision for Tax	0.08	31.31	3.35	1.73	1.02
Profit after Tax	8.61	107.43	9.79	4.80	2.83

Liabilities (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Shareholder's Funds	30.42	1,724.15	14.73	32.17	10.26
Minority Interest	--	46.21	--	--	--
Non-Current Liabilities	2.77	72.84	7.17	0.47	4.16
Current Liabilities	6.80	845.02	16.99	24.46	11.77
Total Liabilities	39.98	2,702.52	39.12	57.15	26.19

Assets (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Non-Current Assets	3.56	612.51	7.81	10.70	2.93
Current Assets	36.42	2,075.71	31.09	46.40	23.26
Total Assets	39.98	2,702.52	39.12	57.15	26.19
Total Debt*	5.05	298.81	15.01	21.77	11.03
Net Current Assets	29.62	1,230.69	14.10	21.95	11.49
Contingent Liabilities	--	4.01	0.05	0.39	0.77

Cashflow (₹ Cr)

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Cash From Operating Activities	-5.79	-76.87	-3.67	-7.89	3.18
Cash Flow from Investing Activities	-2.07	219.80	0.34	-0.55	0.16
Cash from Financing Activities	8.46	-73.66	3.33	-2.38	-2.89
Net Cash Inflow / Outflow	0.60	69.27	0.00	-10.82	0.45

Ratios

Profitability Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
ROCE (%)	34.47	9.16	64.18	16.08	28.82
ROE (%)	37.85	6.40	99.59	14.91	39.06
ROA (%)	27.50	4.29	33.60	8.40	11.54
EBIT Margin (%)	16.13	4.14	40.59	8.77	21.58
Net Margin (%)	14.70	2.09	25.56	4.46	10.10
Cash Profit Margin (%)	15.11	2.71	28.28	5.14	10.99

Growth Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Revenue Growth (%)	111.71	29.92	150.47	0.00	19.05
EBIT Growth (%)	73.88	67.16	170.72	--	40.70
Net Profit Growth (%)	193.43	169.94	292.00	0.00	56.94
EPS Growth (%)	133.30	142.37	292.00	0.00	56.94
Book Value Growth (%)	101.92	5.11	198.35	0.00	39.53

Valuation Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Price / Earnings	0.00	52.15	0.00	0.00	0.00
Price / Book Value	0.00	2.88	0.00	0.00	0.00
Dividend Yield (%)	--	0.00	--	--	--
EV/EBITDA	1.13	23.61	1.56	3.49	3.06
Market Cap (₹ Cr)	0.00	4,944.94	0.00	0.00	0.00

Solvency Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Debt to Equity	0.17	0.17	1.02	0.68	1.08
Short term debt to equity ratio	0.04	0.17	0.43	0.64	0.55
Current Ratio	5.36	2.46	1.83	1.90	1.98
Quick Ratio	2.80	1.68	0.76	1.43	1.40
Interest Coverage	18.03	4.33	10.70	4.03	2.98

Operating Efficiency Ratios

	Speciality Medicines	Entero Health	Bio Medica Laboratories	VijayPD Ceutical	Goldline Pharmaceutical
Debtors to sales (%)	16.45	16.30	10.73	22.28	38.11
Asset Turnover	1.86	2.03	1.31	1.87	1.14
Receivable days	63.57	51.78	30.75	81.32	132.15
Inventory Days	79.57	38.71	121.86	39.42	92.81
Payable days	14.65	24.83	117.74	8.63	64.28
Cash Conversion Cycle	128.49	65.66	34.88	112.12	160.68